Last reviewed · How we verify

Zavegepant 4 x 25mg enteric coated soft gel capsule (zavegepant-4-x-25mg-enteric-coated-soft-gel-capsule)

Pfizer Inc. · Phase 1 active Quality 5/100

Zavegepant 4 x 25mg enteric coated soft gel capsule (generic name: zavegepant-4-x-25mg-enteric-coated-soft-gel-capsule) is a drug developed by Pfizer Inc.. It is currently in Phase 1 development.

At a glance

Generic namezavegepant-4-x-25mg-enteric-coated-soft-gel-capsule
SponsorPfizer Inc.
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Zavegepant 4 x 25mg enteric coated soft gel capsule

What is Zavegepant 4 x 25mg enteric coated soft gel capsule?

Zavegepant 4 x 25mg enteric coated soft gel capsule (zavegepant-4-x-25mg-enteric-coated-soft-gel-capsule) is a pharmaceutical drug developed by Pfizer Inc..

Who makes Zavegepant 4 x 25mg enteric coated soft gel capsule?

Zavegepant 4 x 25mg enteric coated soft gel capsule is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).

What is the generic name of Zavegepant 4 x 25mg enteric coated soft gel capsule?

zavegepant-4-x-25mg-enteric-coated-soft-gel-capsule is the generic (nonproprietary) name of Zavegepant 4 x 25mg enteric coated soft gel capsule.

What development phase is Zavegepant 4 x 25mg enteric coated soft gel capsule in?

Zavegepant 4 x 25mg enteric coated soft gel capsule is in Phase 1.

What are the side effects of Zavegepant 4 x 25mg enteric coated soft gel capsule?

Common side effects of Zavegepant 4 x 25mg enteric coated soft gel capsule include Skin abrasion, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin increased, Lipase increased, White blood cells urine positive.

Related